Rheumatoid arthritis V: therapy with remission-inducing agents
Gaines, L.M.
Maryland State Medical Journal 31(9): 49-50
1982
ISSN/ISBN: 0025-4363 PMID: 6815385 Document Number: 183455
Document emailed within 1 workday
Related Documents
Ichikawa, N.; Yamanaka, H. 2007: Maintenance therapy for rheumatoid arthritis after remission following successful treatment using biologics Nihon Rinsho. Japanese Journal of Clinical Medicine 65(7): 1293-1298Yu, C.; Li, M.; Duan, X.; Fang, Y.; Li, Q.; Wu, R.; Liu, S.; Wang, Y.; Wu, Z.; Shi, X.; Jiang, Z.; Wang, Y.; Hsieh, E.D.; Jin, S.; Jiang, N.; Wang, Q.; Zhao, Y.; Tian, X.; Zeng, X. 2018: Chinese registry of rheumatoid arthritis (CREDIT): I. Introduction and prevalence of remission in Chinese patients with rheumatoid arthritis Clinical and Experimental Rheumatology 36(5): 836-840
Mäkinen, H.; Hannonen, P.; Sokka, T. 2006: Definitions of remission for rheumatoid arthritis and review of selected clinical cohorts and randomised clinical trials for the rate of remission Clinical and Experimental Rheumatology 24(6 Suppl 43: S
Berdnik-Gortan, K.; Bjelinski, D. 1999: Effect of combination therapy and nonsteroidal antirheumatic agents on acute phase reactants in patients with rheumatoid arthritis Reumatizam 46(1): 12-16
Saulsbury, F.T. 1999: Remission of juvenile rheumatoid arthritis with varicella infection Journal of Rheumatology 26(7): 1606-1608
Dessein, P.H.; Lopez-Mejias, R.; Ubilla, B.; Genre, F.; Corrales, A.; Hernandez, J.L.; Ferraz-Amaro, I.; Tsang, L.; Pina, T.; Llorca, J.; Blanco, R.; Gonzalez-Juanatey, C.; Gonzalez-Gay, M.A. 2015: TNF-related apoptosis-inducing ligand and cardiovascular disease in rheumatoid arthritis Clinical and Experimental Rheumatology 33(4): 491-497
Krel', A.A.; Semenova, O.I.; Kanevskaia, M.Z.; Shekhter, A.B. 1994: Drug-induced remission in the severe progressive variant of rheumatoid arthritis Terapevticheskii Arkhiv 66(1): 24-29
Jäntti, J.; Kaarela, K.; Kautiainen, H.; Isomäki, H.; Aho, K. 2001: Radiographic remission in seropositive rheumatoid arthritis. a 20-year follow-up study Clinical and Experimental Rheumatology 19(5): 573-576
Shaver, T.S.; Anderson, J.D.; Weidensaul, D.N.; Shahouri, S.H.; Shahouri, S.S.; Busch, R.E.; Mikuls, T.R.; Michaud, K.; Wolfe, F. 2008: The problem of rheumatoid arthritis disease activity and remission in clinical practice Journal of Rheumatology 35(6): 1015-1022
Le Loët, X.; Vittecoq, O.; Daragon, A. 1998: Combinations of second-line drugs for rheumatoid arthritis: is remission induction a reasonable goal? Revue du Rhumatisme 65(3): 161-164
Wacharapornin, P.; Suwannalai, P. 2014: Predictors for low disease activity and remission in rheumatoid arthritis patients treated with biological DMARDs Journal of the Medical Association of Thailand 97(11): 1157-1163
Lowenthal, R.M.; Francis, H.; Gill, D.S. 2006: Twenty-year remission of rheumatoid arthritis in 2 patients after allogeneic bone marrow transplant Journal of Rheumatology 33(4): 812-813
Goodwin, J.S.; Ceuppens, J.L.; Rodriguez, M.A. 1983: Administration of nonsteroidal anti-inflammatory agents in patients with rheumatoid arthritis. Effects on indexes of cellular immune status and serum rheumatoid factor levels JAMA 250(18): 2485-2488
Sahin, F.; Kotevoglu, N.; Taspinar, S.; Yilmaz, F.; Kuran, B. 2006: Comparison of functional disability scales and their relevance to radiological progression in patients with rheumatoid arthritis in remission Clinical and Experimental Rheumatology 24(5): 540-545
Lin, X.-j.; Cai, X.-y.; Ye, J.-h.; Tang, C.; Li, W.-n.; He, Z.-x. 2013: Detection significance of Th17 cells in peripheral blood of patients with rheumatoid arthritis in clinical remission Zhonghua Yi Xue Za Zhi 93(29): 2305-2308
Furst, D.E.; Schiff, M.H.; Fleischmann, R.M.; Strand, V.; Birbara, C.A.; Compagnone, D.; Fischkoff, S.A.; Chartash, E.K. 2003: Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis) Journal of Rheumatology 30(12): 2563-2571
Laganà, B.; Picchianti Diamanti, A.; Germano, V.; Argento, G.; Ferlito, C.; D Amelio, R. 2008: Two-year follow-up in an early rheumatoid arthritis patient treated with etanercept: radiological involvement despite clinical remission Journal of Biological Regulators and Homeostatic Agents 22(4): 271-273
Pincus, T.; Sokka, T. 2001: Quantitative target values of predictors of mortality in rheumatoid arthritis as possible goals for therapeutic interventions: an alternative approach to remission or ACR20 responses? Journal of Rheumatology 28(7): 1723-1734
Merkel, P.A.; Letourneau, E.N.; Polisson, R.P. 1995: Investigational agents for rheumatoid arthritis Rheumatic Diseases Clinics of North America 21(3): 779-796
Vázquez, I.; Graell, E.; Gratacós, J.; Cañete, J.D.; Viñas, O.; Ercilla, M.G.; Gómez, A.; Hernández, M.V.; Rodríguez-Cros, J.R.; Larrosa, M.; Sanmartí, R. 2007: Prognostic markers of clinical remission in early rheumatoid arthritis after two years of DMARDs in a clinical setting Clinical and experimental rheumatology 25(2): 231-238